|
SereventDrug - Serevent The trade name of the product as shown on the labeling.
Dosage -
POWDER; INHALATION
Active Ingredient(s) -
Salmeterol Xinafoate
Strength -
EQ 0.046MG BASE/INH
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
020692
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 19, 1997
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Glaxosmithkline
Serevent
Liposyn Ii 20% 10%;10% (10gm/100ml) Injectable; Injection
Serevent Eq 0.021mg Base/inh Aerosol, Metered; Inhalation Serevent Eq 0.046mg Base/inh Powder; Inhalation Crestor 40mg Tablet; Oral Crestor 5mg Tablet; Oral Cardiogen-82 N/a Injectable; Injection Sucraid 8,500 Iu/ml Solution; Oral Liposyn 10% 10% (10gm/100ml) Injectable; Injection Liposyn 20% 20% (20gm/100ml) Injectable; Injection Liposyn Ii 10% 5%;5% (5gm/100ml) Injectable; Injection NewDrugInformation |